What is clock.bio?
Founded on the vision to increase human healthspan, clock.bio is dedicated to developing novel treatments that can prevent and treat age-related diseases by decoding the rejuvenation programs present in human cells. The company operates as a partnership of scientists and operators united by a shared ethical outlook, believing that rejuvenation treatments should be universally accessible. This focus positions clock.bio at the forefront of the burgeoning longevity and biotech sectors, aiming to address a critical unmet need in healthcare.
How much funding has clock.bio raised?
clock.bio has raised a total of $5.3M across 1 funding round:
Angel/Seed
$5.3M
Angel/Seed (2024): $5.3M with participation from BlueYard Capital, Onsight Ventures, and LocalGlobe
Key Investors in clock.bio
BlueYard Capital
BlueYard Capital is a venture capital firm that invests in innovative technologies across various sectors, including computation, engineering, biology, and cryptocurrency. The firm focuses on supporting founders who are building solutions that contribute to a better future while addressing significant global challenges.
Onsight Ventures
Onsight Ventures is a deep tech investment fund based in Innsbruck that focuses on empowering European founders to become global leaders in technology-driven sectors. The firm invests in early-stage companies with significant scaling potential, covering areas such as gene therapy, quantum computing, and synthetic biology.
LocalGlobe
LocalGlobe is a venture capital firm known for its early-stage investments in technology companies. The firm typically backs ambitious founders building disruptive businesses across various sectors, with a focus on creating significant market impact.
What's next for clock.bio?
The recent major strategic investment signals a pivotal growth phase for clock.bio. This capital infusion is expected to accelerate the company's research and development efforts, potentially enabling the advancement of its therapeutic candidates through preclinical and clinical trials. The company's commitment to making rejuvenation treatments accessible suggests a long-term strategy focused on broad market impact and sustainable growth within the healthspan industry.
See full clock.bio company page
